Enfusion Stock Market Value
| ENFN Stock | USD 9.67 0.03 0.31% |
| Symbol | Enfusion |
Enfusion Price To Book Ratio
Is Enfusion's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enfusion. If investors know Enfusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enfusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.94) | Earnings Share 0.02 | Revenue Per Share 2.055 | Quarterly Revenue Growth 0.173 | Return On Assets 0.0331 |
The market value of Enfusion is measured differently than its book value, which is the value of Enfusion that is recorded on the company's balance sheet. Investors also form their own opinion of Enfusion's value that differs from its market value or its book value, called intrinsic value, which is Enfusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enfusion's market value can be influenced by many factors that don't directly affect Enfusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enfusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enfusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enfusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Enfusion 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Enfusion's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Enfusion.
| 04/20/2024 |
| 05/20/2024 |
If you would invest 0.00 in Enfusion on April 20, 2024 and sell it all today you would earn a total of 0.00 from holding Enfusion or generate 0.0% return on investment in Enfusion over 30 days. Enfusion is related to or competes with S A P, Tyler Technologies, Roper Technologies, Cadence Design, PTC, Manhattan Associates, and ANSYS. Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe,... More
Enfusion Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Enfusion's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Enfusion upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.19 | |||
| Information Ratio | 0.0204 | |||
| Maximum Drawdown | 15.08 | |||
| Value At Risk | (2.91) | |||
| Potential Upside | 2.31 |
Enfusion Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Enfusion's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Enfusion's standard deviation. In reality, there are many statistical measures that can use Enfusion historical prices to predict the future Enfusion's volatility.| Risk Adjusted Performance | 0.0465 | |||
| Jensen Alpha | 0.0446 | |||
| Total Risk Alpha | (0.19) | |||
| Sortino Ratio | 0.0199 | |||
| Treynor Ratio | 0.1346 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Enfusion's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Enfusion Backtested Returns
We consider Enfusion not too volatile. Enfusion secures Sharpe Ratio (or Efficiency) of 0.0397, which denotes the company had a 0.0397% return per unit of risk over the last 3 months. We have found thirty technical indicators for Enfusion, which you can use to evaluate the volatility of the firm. Please confirm Enfusion's Coefficient Of Variation of 1493.83, downside deviation of 2.19, and Mean Deviation of 1.42 to check if the risk estimate we provide is consistent with the expected return of 0.0851%. Enfusion has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.99, which means possible diversification benefits within a given portfolio. Enfusion returns are very sensitive to returns on the market. As the market goes up or down, Enfusion is expected to follow. Enfusion right now shows a risk of 2.14%. Please confirm Enfusion downside variance, day median price, and the relationship between the treynor ratio and kurtosis , to decide if Enfusion will be following its price patterns.
Auto-correlation | -0.02 |
Very weak reverse predictability
Enfusion has very weak reverse predictability. Overlapping area represents the amount of predictability between Enfusion time series from 20th of April 2024 to 5th of May 2024 and 5th of May 2024 to 20th of May 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Enfusion price movement. The serial correlation of -0.02 indicates that only 2.0% of current Enfusion price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.02 | |
| Spearman Rank Test | -0.43 | |
| Residual Average | 0.0 | |
| Price Variance | 0.07 |
Enfusion lagged returns against current returns
Autocorrelation, which is Enfusion stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Enfusion's stock expected returns. We can calculate the autocorrelation of Enfusion returns to help us make a trade decision. For example, suppose you find that Enfusion has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Enfusion regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Enfusion stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Enfusion stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Enfusion stock over time.
Current vs Lagged Prices |
| Timeline |
Enfusion Lagged Returns
When evaluating Enfusion's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Enfusion stock have on its future price. Enfusion autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Enfusion autocorrelation shows the relationship between Enfusion stock current value and its past values and can show if there is a momentum factor associated with investing in Enfusion.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Enfusion Correlation, Enfusion Volatility and Enfusion Alpha and Beta module to complement your research on Enfusion. To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.Note that the Enfusion information on this page should be used as a complementary analysis to other Enfusion's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for Enfusion Stock analysis
When running Enfusion's price analysis, check to measure Enfusion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enfusion is operating at the current time. Most of Enfusion's value examination focuses on studying past and present price action to predict the probability of Enfusion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enfusion's price. Additionally, you may evaluate how the addition of Enfusion to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
Enfusion technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.